Lakshmi Nayak, MD

Neuro-oncology

Lakshmi Nayak, MD

View full profile

Related Videos

Phase 2 PROSPECT Study Presented by Lakshmi Nayak, MD. Video

Phase 2 PROSPECT Study Presented by Lakshmi Nayak, MD.

Lakshmi Nayak, MD presented results from a phase 2 PROSPECT study focused on tirabrutinib and it's effect on patients with relapsed or refractory primary central nervous system lymphoma.

Lakshmi Nayak, MD Discusses CNS Lymphoma Video

Lakshmi Nayak, MD Discusses CNS Lymphoma

CNS Lymphoma research at ASCO24: Dana-Farber's Lakshmi Nayak, MD, details findings of a pilot study showing a CAR T-cell therapy has shown promise and is safe and well-tolerated in treating patients with relapsed, treatment-resistant CNS lymphoma.